loadpatents
name:-0.01096510887146
name:-0.017162084579468
name:-0.0013930797576904
Breault; Gloria Anne Patent Filings

Breault; Gloria Anne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Breault; Gloria Anne.The latest application filed is for "imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation".

Company Profile
0.13.7
  • Breault; Gloria Anne - Macclesfield GB
  • Breault; Gloria Anne - Congleton GB
  • Breault, Gloria Anne - Cheshire GB
  • Breault, Gloria Anne - Macclesfield Cheshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2,4-diamino pyrimidine compounds having anti-cell proliferative activity
Grant 7,176,212 - Breault , et al. February 13, 2
2007-02-13
Pyrimidine compounds
Grant 7,153,964 - Pease , et al. December 26, 2
2006-12-26
Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
App 20060004033 - Breault; Gloria Anne ;   et al.
2006-01-05
Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
Grant 6,969,714 - Breault , et al. November 29, 2
2005-11-29
2,4-Diamino pyrimidine compounds having anti-cell proliferative activity
App 20050090493 - Breault, Gloria Anne ;   et al.
2005-04-28
Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivatives
Grant 6,855,719 - Thomas , et al. February 15, 2
2005-02-15
Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
Grant 6,787,562 - Breault , et al. September 7, 2
2004-09-07
Pyrimidine compounds
Grant 6,710,052 - Pease , et al. March 23, 2
2004-03-23
Imidazolo-5-YL-2anilino-pyrimidines as agents for the inhibition of the cell proliffration
App 20040014776 - Breault, Gloria Anne ;   et al.
2004-01-22
2,4-di(hetero-)arylamino (oxy)-5-substituted pyrimidines as antineoplastic agents
Grant 6,649,608 - Pease , et al. November 18, 2
2003-11-18
Pyrimidine compounds
Grant 6,632,820 - Breault , et al. October 14, 2
2003-10-14
Pyrimidine compounds
App 20030149064 - Pease, Elizabeth Janet ;   et al.
2003-08-07
2,4-Di(hetero-)arylamino (oxy)-5-substituted pyrimidines as antineoplastic agents
App 20030149266 - Pease, Elizabeth Janet ;   et al.
2003-08-07
Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
App 20030139418 - Breault, Gloria Anne ;   et al.
2003-07-24
Pyrimidine compounds
App 20030114473 - Pease, Elizabeth Janet ;   et al.
2003-06-19
Aromatic amine compounds that antagonize the pain enhancing effects of prostaglandins
Grant 6,100,258 - Breault
2000-08-08
Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
Grant 6,057,345 - Breault , et al. May 2, 2
2000-05-02
Aromatic compounds and pharmaceutical compositions containing them
Grant 5,994,353 - Breault November 30, 1
1999-11-30
Aromatic amino ethers as pain relieving agents
Grant 5,843,942 - Breault , et al. December 1, 1
1998-12-01
Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
Grant 5,834,468 - Breault , et al. November 10, 1
1998-11-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed